Abstract

Gastrointestinal stromal tumours (GISTs) rarely occur in young adults; in this age group, succinate dehydrogenase (SDH)-deficient subtypes predominate and may signal hereditary tumor syndromes. We present a 23-year-old male with a prior carotid paraganglioma who developed life-threatening iron deficiency anaemia (haemoglobin 4.0 g/dl) as the presenting manifestation of a high-grade gastric GIST. Subtotal gastrectomy with Billroth II reconstruction achieved R0 resection. Molecular testing was negative for KIT and PDGFRA mutations. Given the patient’s age, mixed epithelioid/spindle histology, wild-type molecular profile, and paraganglioma history, Carney–Stratakis syndrome was suspected. SDHB immunohistochemistry confirmed an SDH-deficient phenotype, and germline testing identified a pathogenic heterozygous SDHx variant, establishing the diagnosis of Carney–Stratakis syndrome. At follow-up, the patient was clinically stable and enrolled in a multidisciplinary surveillance program. This case highlights the importance of recognizing atypical hematologic presentations of GIST and the need for comprehensive molecular and genetic evaluation in young patients.

Introduction

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract, arising from interstitial cells of Cajal [1]. While most arise in older adults and harbor activating KIT or PDGFRA mutations, ~10%–15% are wild-type [2]. Among these, succinate dehydrogenase (SDH)-deficient GISTs disproportionately affect young patients and may herald hereditary syndromes such as Carney-Stratakis syndrome (CSS)—defined by the co-occurrence of GIST and paraganglioma due to germline SDH subunit mutations [3, 4]. Life-threatening anaemia as the sentinel presentation is uncommon and can delay recognition. We describe the surgical management and post-operative surveillance strategy for a young patient with suspected CSS presenting in this atypical fashion.

Case report

A 23-year-old male with a history of left carotid paraganglioma (Shamblin type II) resected in 2023 presented with a 2-week history of chest pain, exertional dyspnea, palpitations, and an episode of hematemesis. Haemoglobin was 4.0 g/dl with serum iron <10 μg/dl and ferritin 0.8 ng/ml, consistent with profound iron deficiency anaemia. Computed tomography (CT) abdomen/pelvis demonstrated a 3.9 × 4.2 × 5.8 cm lobulated, heterogeneously enhancing mass along the lesser curvature with an exophytic component and no peritoneal metastases.

Following transfusion of three packed red blood cell units, urgent esophagogastroduodenoscopy identified a malignant-appearing gastric antral mass with irregular, ulcerated mucosa (Fig. 1). Biopsy demonstrated chronic active gastritis with ulceration.

Four endoscopic images of the stomach showing a large, lobulated gastric mass with ulcerated, necrotic surface and an area of active mucosal bleeding.
Figure 1

Esophagogastroduodenoscopy demonstrating a large gastric antral mass with lobulated, ulcerated, and necrotic surface (A, C; yellow arrows demarcate margins), submucosal endoluminal component (B), and active mucosal bleeding (D, arrow) consistent with hematemesis.

The patient underwent exploratory laparotomy with subtotal gastrectomy, Billroth II reconstruction, Braun anastomosis, jejunostomy tube placement, and omental flap coverage. Intraoperative findings confirmed a large exophytic mass along the lesser curvature without peritoneal or hepatic involvement. Post-operatively, he tolerated diet advancement and maintained haemoglobin 9.5–10.5 g/dl.

Final pathology revealed a 6.5 × 4.6 × 3.7 cm GIST, mixed epithelioid and spindle cell type, high grade (G2), with 12 mitoses per 5 mm2 (Fig. 2). All margins and three lymph nodes were negative (pT3N0). CD117, CD34, and DOG1 were positive (Fig. 3). Next-generation sequencing returned negative for KIT (exons 2, 3, 8–11, 13, 14, 17–19) and PDGFRA (exons 5, 6, 11, 12, 14, 16, 18). H. pylori immunostaining on background mucosa was positive. Given the patient’s age, wild-type molecular profile, mixed morphology, and paraganglioma history, SDH-deficient GIST with CSS was suspected. SDHB immunohistochemistry demonstrated loss of cytoplasmic staining in tumor cells with preserved internal control staining, confirming an SDH-deficient phenotype. Germline testing identified a pathogenic heterozygous SDHx variant, establishing the diagnosis of Carney-Stratakis syndrome. At follow-up, the patient remained clinically stable with improving postoperative anaemia, tolerance of oral intake, and no clinical evidence of recurrent gastrointestinal bleeding. He was enrolled in a multidisciplinary surveillance program including serial CT or magnetic resonance imaging (MRI) of the abdomen and pelvis every 3–6 months, whole-body functional imaging to evaluate for occult paraganglioma or pheochromocytoma, and annual biochemical testing with plasma or urine metanephrines/catecholamines.

Four histopathology images of resected gastric tissue showing tumor cells under low, medium, and high magnification, plus a positive CD117 immunostain.
Figure 2

Histopathology of resected gastric GIST. (A) Low-power H&E: Submucosal mass with intact serosa. (B) Medium-power H&E: Mixed epithelioid (solid arrow) and spindle cell (dotted arrow) morphology. (C) High-power H&E: Brisk mitotic activity (circled), 12 mitoses/5 mm2. (D) CD117 immunostaining: Diffuse cytoplasmic positivity.

Microscopic image of tumor tissue showing positive DOG1 immunohistochemical staining.
Figure 3

DOG1 immunohistochemistry showing diffuse membranous and cytoplasmic positivity, confirming GIST diagnosis.

Discussion

This case highlights three instructive features. First, life-threatening anaemia (haemoglobin 4.0 g/dl) as the primary presentation of gastric GIST is unusual. Profound unexplained iron deficiency anaemia in young patients should prompt aggressive endoscopic and cross-sectional imaging evaluation, even when classic GI symptoms are absent.

Second, the wild-type KIT/PDGFRA molecular profile, mixed epithelioid histology, young age, and concurrent paraganglioma history are collectively highly suggestive of SDH-deficient GIST and CSS [4, 5]. CSS is autosomal dominant, caused by germline SDH subunit mutations (SDHB/C/D), and is characterized by the dyad of GIST and paraganglioma [4, 6]. SDH-deficient GISTs respond poorly to imatinib, making accurate molecular subtyping critical for systemic therapy decisions [3, 7].

Third, the confirmed SDH-deficient phenotype and pathogenic germline SDHx variant establish this as CSS with direct management implications. A structured multidisciplinary surveillance plan was implemented: serial CT or MRI of the abdomen and pelvis every 3–6 months during the initial postoperative period given high-risk pathology (pT3, G2, 12 mitoses/5 mm2), then annually thereafter [8]. Whole-body 68Ga-DOTATATE PET/CT has been scheduled to assess for occult paraganglioma or pheochromocytoma [9]. Annual 24-hour urine catecholamines and metanephrines are being monitored given the paraganglioma history. Once germline results are available, first-degree relatives will be referred for genetic counseling and SDH mutation testing [6]. At follow-up, the patient remained clinically stable with improving postoperative anaemia, tolerance of oral intake, and no clinical evidence of recurrent gastrointestinal bleeding.

Surgical resection with R0 margins remains the cornerstone of localized GIST management [10]. This case underscores that in young patient with wild-type GIST and a personal or family history of paraganglioma, CSS should be suspected, SDH IHC and germline testing pursued, and a multidisciplinary surveillance framework established at the time of surgery.

Conflicts of interest

None declared.

Funding

None declared.

References

1.

Nishida
 
T
,
Blay
 
JY
,
Hirota
 
S
 et al.  
Gastrointestinal stromal tumours
.
Nat Rev Dis Primers
 
2023
;
9
:
1
20
.

2.

Miettinen
 
M
,
Wang
 
ZF
,
Sarlomo-Rikala
 
M
 et al.  
Succinate dehydrogenase–deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study
.
Am J Surg Pathol
 
2011
;
35
:
1712
21
.

3.

Boikos
 
SA
,
Pappo
 
AS
,
Killian
 
JK
 et al.  
Molecular subtypes of GISTs and their therapeutic implications
.
JAMA Oncol
 
2016
;
2
:
922
8
.

4.

Pasini
 
B
,
McWhinney
 
SR
,
Bei
 
T
 et al.  
Clinical and molecular genetics of Carney-Stratakis syndrome
.
Eur J Hum Genet
 
2008
;
16
:
79
88
.

5.

Janeway
 
KA
,
Kim
 
SY
,
Lodish
 
M
 et al.  
Defects in succinate dehydrogenase in GISTs lacking KIT and PDGFRA mutations
.
Proc Natl Acad Sci U S A
 
2011
;
108
:
314
8
.

6.

Gill
 
AJ
.
Succinate dehydrogenase (SDH)-deficient neoplasia
.
Histopathology
 
2018
;
72
:
106
16
.

7.

Pantaleo
 
MA
,
Astolfi
 
A
,
Indio
 
V
 et al.  
Advances in the molecular biology and treatment of GISTs
.
Cancers (Basel)
 
2023
;
15
:
787
.

8.

Schaefer
 
IM
,
Wang
 
Y
,
Liang
 
CW
 et al.  
SDH-deficient GISTs: a clinicopathologic and molecular characterization
.
Mod Pathol
 
2022
;
35
:
1
10
.

9.

Jha
 
A
,
Ling
 
A
,
Millo
 
C
 et al.  
Clinical, diagnostic, and treatment characteristics of SDH-deficient tumors
.
Endocr Rev
 
2021
;
42
:
709
38
.

10.

Dematteo
 
RP
,
Lewis
 
JJ
,
Leung
 
D
 et al.  
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors
.
Ann Surg
 
2000
;
231
:
51
8
.

Author notes

Nakul Ganju and Chukwunonso Ndulue contributed equally to this work and share first authorship.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.